Adoptive transfer of CMV- and EBV-specific peptide-stimulated T cells after allogeneic stem cell transplantation: First results of a phase I/IIa clinical trial [AIT-MULTIVIR-01].
Oncol. Res. Treat.40, 239-239 (2017)
Open Access Green möglich sobald Postprint bei der ZB eingereicht worden ist.